Literature DB >> 26337973

Serum Leptin Levels and the Risk of Stroke: The Framingham Study.

Hamidreza Saber1, Jayandra J Himali2, Ashkan Shoamanesh2, Alexa Beiser2, Aleksandra Pikula2, Tamara B Harris2, Ronenn Roubenoff2, Jose Rafael Romero2, Carlos S Kase2, Ramachandran S Vasan2, Sudha Seshadri2.   

Abstract

BACKGROUND AND
PURPOSE: Leptin is a major adipokine that regulates weight balance and energy homeostasis. There is inconsistent evidence linking circulating leptin levels to risk of stroke. We tested the hypothesis that leptin levels are associated with risk of incident stroke in an elderly community based sample.
METHODS: Serum leptin levels were assayed in 757 stroke free individuals (mean age, 79 years; 62% women) from the Framingham Original Cohort at the 22nd examination cycle (1990-1994). Incidence of all -stroke and ischemic stroke were prospectively ascertained.
RESULTS: During a mean follow up of 10 years, 119 individuals developed stroke (99 ischemic strokes). In multivariable Cox regression models, log leptin levels were not associated with incidence of all -stroke or ischemic stroke (hazard ratios per SD increment in log leptin 0.90 [0.73-1.09] and 0.89 [0.72-1.11], respectively). The results were suggestive for potential effect modification by waist/hip ratio for the association between leptin and stroke (P=0.03). Adjusting for age, sex, and established stroke risk factors, analysis stratified by waist/hip ratio quartiles revealed a lower incidence of first-ever all-stroke and ischemic stroke associated with higher leptin levels among only subjects in the top waist/hip ratio quartile (hazard ratio, 0.64 [0.43, 0.95] versus 0.98 [0.77, 1.25] for incident all-stroke and 0.61 [0.39, 0.95] versus 0.96 [0.74, 1.26] for ischemic stroke).
CONCLUSIONS: Leptin levels were not directly related to the risk of incident stroke overall but there was an inverse association with stroke in the top waist/hip ratio quartile. Further investigations are required to confirm these findings and explore possible mechanisms for the observed association.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  adipokines; leptin; obesity; risk; stroke

Mesh:

Substances:

Year:  2015        PMID: 26337973      PMCID: PMC4589501          DOI: 10.1161/STROKEAHA.115.009463

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  49 in total

1.  Probability of stroke: a risk profile from the Framingham Study.

Authors:  P A Wolf; R B D'Agostino; A J Belanger; W B Kannel
Journal:  Stroke       Date:  1991-03       Impact factor: 7.914

Review 2.  Unraveling the central nervous system pathways underlying responses to leptin.

Authors:  J K Elmquist; E Maratos-Flier; C B Saper; J S Flier
Journal:  Nat Neurosci       Date:  1998-10       Impact factor: 24.884

3.  Impact of leptin-mediated sympatho-activation on cardiovascular function in obese mice.

Authors:  Eric J Belin de Chantemèle; James D Mintz; William E Rainey; David W Stepp
Journal:  Hypertension       Date:  2011-06-20       Impact factor: 10.190

4.  High leptin levels are associated with stroke.

Authors:  Stefan Söderberg; Birgitta Stegmayr; Christine Ahlbeck-Glader; Lisbeth Slunga-Birgander; Bo Ahrén; Tommy Olsson
Journal:  Cerebrovasc Dis       Date:  2003       Impact factor: 2.762

5.  Leptin: a molecule integrating somatic energy stores, energy expenditure and fertility.

Authors:  M Rosenbaum; R L Leibel
Journal:  Trends Endocrinol Metab       Date:  1998-04       Impact factor: 12.015

6.  Absence of leptin resistance in platelets from morbidly obese individuals may contribute to the increased thrombosis risk in obesity.

Authors:  Claudia Dellas; Katrin Schäfer; Ilonka Rohm; Mareike Lankeit; Thomas Ellrott; Vivien Faustin; Joachim Riggert; Gerd Hasenfuss; Stavros Konstantinides
Journal:  Thromb Haemost       Date:  2008-12       Impact factor: 5.249

7.  Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population.

Authors:  Abel Romero-Corral; Justo Sierra-Johnson; Francisco Lopez-Jimenez; Randal J Thomas; Prachi Singh; Michal Hoffmann; Aynur Okcay; Josef Korinek; Robert Wolk; Virend K Somers
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-04-22

8.  Low serum leptin predicts mortality in patients with chronic kidney disease stage 5.

Authors:  Alexandra Scholze; Dirk Rattensperger; Walter Zidek; Martin Tepel
Journal:  Obesity (Silver Spring)       Date:  2007-06       Impact factor: 5.002

9.  The obesity paradox in men with coronary heart disease and heart failure: the role of muscle mass and leptin.

Authors:  S Goya Wannamethee; A Gerald Shaper; Peter H Whincup; Lucy Lennon; Olia Papacosta; Naveed Sattar
Journal:  Int J Cardiol       Date:  2013-11-23       Impact factor: 4.164

10.  Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population.

Authors:  Paul Welsh; Heather M Murray; Brendan M Buckley; Anton J M de Craen; Ian Ford; J Wouter Jukema; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G J Westendorp; James Shepherd; Naveed Sattar
Journal:  Diabetes Care       Date:  2008-11-10       Impact factor: 19.112

View more
  7 in total

1.  Leptin trajectories from birth to mid-childhood and cardio-metabolic health in early adolescence.

Authors:  Ling-Jun Li; Sheryl L Rifas-Shiman; Izzuddin M Aris; Christos Mantzoros; Marie-France Hivert; Emily Oken
Journal:  Metabolism       Date:  2018-11-07       Impact factor: 8.694

Review 2.  Leptin, cardiovascular diseases and type 2 diabetes mellitus.

Authors:  Niki Katsiki; Dimitri P Mikhailidis; Maciej Banach
Journal:  Acta Pharmacol Sin       Date:  2018-06-07       Impact factor: 6.150

Review 3.  Leptin in Leanness and Obesity: JACC State-of-the-Art Review.

Authors:  Nikolaos Perakakis; Olivia M Farr; Christos S Mantzoros
Journal:  J Am Coll Cardiol       Date:  2021-02-16       Impact factor: 24.094

Review 4.  Leptin concentration and risk of coronary heart disease and stroke: A systematic review and meta-analysis.

Authors:  Han Yang; Wenzhi Guo; Jie Li; Shengli Cao; Jiakai Zhang; Jie Pan; Zhihui Wang; Peihao Wen; Xiaoyi Shi; Shuijun Zhang
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

5.  Correlation between CH2DS2-VASc Score and Serum Leptin Levels in Cardioembolic Stroke Patients: The Impact of Metabolic Syndrome.

Authors:  Anna Szczepańska-Szerej; Jacek Kurzepa; Aneta Grabarska; Joanna Bielewicz; Ewa Wlizło-Dyś; Konrad Rejdak
Journal:  Int J Endocrinol       Date:  2017-10-31       Impact factor: 3.257

6.  Independent ischemic stroke risk factors in older Americans: a systematic review.

Authors:  Jonathan Singer; Deborah Gustafson; Caroline Cummings; Aron Egelko; Jack Mlabasati; Alyssa Conigliaro; Steven R Levine
Journal:  Aging (Albany NY)       Date:  2019-05-24       Impact factor: 5.682

7.  Leptin Promotes Angiogenesis via Pericyte STAT3 Pathway upon Intracerebral Hemorrhage.

Authors:  Qi Cui; Yingmei Zhang; Ning Tian; Jiaxin Yang; Dongshan Ya; Wenjing Xiang; Zixian Zhou; Yanlin Jiang; Jungang Deng; Bin Yang; Xiaohui Lin; Qinghua Li; Rujia Liao
Journal:  Cells       Date:  2022-09-03       Impact factor: 7.666

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.